This story was first published in digitalhealth.net
New therapy rolled out for patients with womb cancer
NHS England is to roll out a new life-extending combination therapy for patients with womb cancer, that can halt the progression of the disease for twice as long as chemotherapy.
The NHS has agreed commercial deals for two drugs from different manufacturers, which will be used in combination to treat advanced endometrial cancer in between 500 and 750 patients each year.
When used together, clinical trials have shown that pembrolizumab (Keytruda®) and lenvatinib (Lenvima®) can double the time taken for cancer to progress compared with the existing chemotherapy treatment, from just over three and half months to more than seven months.
The trial also showed longer survival for those taking the combination therapy.
As part of the combination treatment, pembrolizumab is delivered intravenously every three or six weeks while lenvatinib is two pills taken once a day.
NHS national cancer director Professor Peter Johnson said: “It is fantastic news that this innovative combination therapy can now offer a new lifeline to hundreds of women living with advanced endometrial cancer, giving hope of precious extra time to live with a better quality of life.”
“Now in its 75th year, the NHS is leading the world in making the latest treatments available through its unique commercial capabilities and commitment to innovation on behalf of patients and their families across the country.”
Minister for health Helen Whately said: “We are working with the NHS and world leading scientists to support new cancer treatments like these – improving the lives of hundreds of women diagnosed with womb cancer.
“Cancer survival rates are improving and record numbers of people are receiving treatment.
“But we know there’s more to do. That’s why today we announced our call for evidence to inform our Major Conditions Strategy – a plan to better diagnose and manage six conditions including cancer.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
